Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Beatrice, Schell"'
Autor:
Elias A. T. Koch, Anne Petzold, Edgar Dippel, Michael Erdmann, Anja Gesierich, Ralf Gutzmer, Jessica C. Hassel, Sebastian Haferkamp, Katharina C. Kähler, Nicole Kreuzberg, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Markus Meissner, Peter Mohr, Claudia Pföhler, Farnaz Rahimi, Beatrice Schell, Patrick Terheyden, Kai-Martin Thoms, Selma Ugurel, Jens Ulrich, Jochen Utikal, Michael Weichenthal, Fabian Ziller, Carola Berking, Markus V. Heppt
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionDespite recent advancements in the treatment of metastatic uveal melanoma (UM), the availability of further treatment options remains limited and the prognosis continues to be poor in many cases. In addition to tebentafusp, immune checkpo
Externí odkaz:
https://doaj.org/article/e37aacd9f05d43b681af7a4bbdfeb024
Autor:
Elias A T, Koch, Anne, Petzold, Anja, Wessely, Edgar, Dippel, Anja, Gesierich, Ralf, Gutzmer, Jessica C, Hassel, Sebastian, Haferkamp, Bettina, Hohberger, Katharina C, Kähler, Harald, Knorr, Nicole, Kreuzberg, Ulrike, Leiter, Carmen, Loquai, Friedegund, Meier, Markus, Meissner, Peter, Mohr, Claudia, Pföhler, Farnaz, Rahimi, Dirk, Schadendorf, Beatrice, Schell, Max, Schlaak, Patrick, Terheyden, Kai-Martin, Thoms, Beatrice, Schuler-Thurner, Selma, Ugurel, Jens, Ulrich, Jochen, Utikal, Michael, Weichenthal, Fabian, Ziller, Carola, Berking, Markus V, Heppt, On Behalf Of The German Dermatologic Cooperative Oncology Group DeCOG Committee Ocular Melanoma
Publikováno v:
Cancers
Volume 13
Issue 13
Cancers, Vol 13, Iss 3359, p 3359 (2021)
Volume 13
Issue 13
Cancers, Vol 13, Iss 3359, p 3359 (2021)
Background: Since there is no standardized and effective treatment for advanced uveal melanoma (UM), the prognosis is dismal once metastases develop. Due to the availability of immune checkpoint blockade (ICB) in the real-world setting, the prognosis
Autor:
Elias A. T. Koch, Anne Petzold, Anja Wessely, Edgar Dippel, Anja Gesierich, Ralf Gutzmer, Jessica C. Hassel, Sebastian Haferkamp, Katharina C. Kähler, Harald Knorr, Nicole Kreuzberg, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Markus Meissner, Peter Mohr, Claudia Pföhler, Farnaz Rahimi, Dirk Schadendorf, Beatrice Schell, Max Schlaak, Patrick Terheyden, Kai-Martin Thoms, Beatrice Schuler-Thurner, Selma Ugurel, Jens Ulrich, Jochen Utikal, Michael Weichenthal, Fabian Ziller, Carola Berking, Markus V. Heppt
Publikováno v:
Cancers, Vol 14, Iss 518, p 518 (2022)
Cancers; Volume 14; Issue 3; Pages: 518
Cancers; Volume 14; Issue 3; Pages: 518
Simple Summary The era of immune checkpoint blockade (ICB) with nivolumab and pembrolizumab (anti-PD-1) alone or in combination with ipilimumab (anti-CTLA-4) has led to prolonged survival in patients with cutaneous melanoma (CM). However, the respons
Autor:
Sebastian Haferkamp, Beatrice Schell, Andrea Forschner, Friedegund Meier, Patrick Terheyden, Markus V. Heppt, Irmgard Bumeder, Carmen Loquai, Jochen Utikal, Christoph Schmid-Tannwald, Felix Kiecker, Lucie Heinzerling, Susanne G. Schäd, David Rafei-Shamsabadi, M. Huber, Markus Meissner, Michael C. Kirchberger, Rudolf A. Herbst, Christiane Pfeiffer, Mirjana Ziemer, Julia K. Tietze, Thomas Eigentler, Katharina C. Kähler, Carola Berking, Daniela Göppner
Publikováno v:
European Journal of Cancer. 82:56-65
Background: Uveal melanoma (UM) is an ocular malignancy with high potential for metastatic spread. In contrast to cutaneous melanoma, immunotherapy has not yet shown convincing efficacy in patients with UM. Combined immune checkpoint blockade with ch
Autor:
Fanny Matheis, Rudolf A. Herbst, Thomas Eigentler, Julia K. Tietze, Carmen Loquai, Katharina C. Kähler, Beatrice Schell, Jens Ulrich, Carola Berking, Bastian Schilling, Edgar Dippel, Erwin S. Schultz, Daniela Göppner, Susanne G. Schäd, Markus V. Heppt, Thilo Gambichler
Publikováno v:
Cancer immunology, immunotherapy : CII. 65(8)
Growing evidence suggests that concurrent loco-regional and systemic treatment modalities may lead to synergistic anti-tumor effects in advanced melanoma. In this retrospective multicenter study, we evaluate the use of electrochemotherapy (ECT) combi